logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Price and purity information (PPP)

Statistics found here the category is Drug availability and drug markets: price and purity information (PPP)

Category Title
PPP PPP-1. Indexed trends in EU retail prices for major drug types, adjusting for inflation, 2004–09
PPP PPP-1. Price of cannabis products at retail level, 2009 Part (i) Minimum, maximum, mean, median and modal price in euros
PPP PPP-1. Price of cannabis products at retail level, 2009 Part (ii) Sources of information
PPP PPP-1. Price of cannabis products at retail level Part (iii) Geographical coverage / Methodology
PPP PPP-2. Indexed trends in EU potency/purity for major drug types, adjusting for population size, 2004-2009
PPP PPP-2. Price of heroin at retail level, 2009 Part (i) Minimum, maximum, mean, median and modal price in euros
PPP PPP-2. Price of heroin at retail level, 2009 Part (ii) Sources of information
PPP PPP-2. Price of heroin at retail level Part (iii) Geographical coverage / Methodology
PPP PPP-3. Price of cocaine products at retail level, 2009 Part (i) Minimum, maximum, mean, median and modal price in euros
PPP PPP-3. Price of cocaine products at retail level, 2009 Part (ii) Sources of information
PPP PPP-3. Price of cocaine products at retail level, 2009 Part (iii) Geographical coverage / Methodology
PPP PPP-4. Price of synthetic drugs at retail level, 2009 Part (i) Minimum, maximum, mean, median and modal price in euros
PPP PPP-4. Price of synthetic drugs at retail level, 2009 Part (ii) Sources of information
PPP PPP-4. Price of synthetic drugs at retail level, 2009 Part (iii) Geographical coverage / Methodology
PPP PPP-5. Potency of cannabis products at retail level, 2009 Part (i) Minimum, maximum, mean, median and modal potency recorded, measured as percentage of THC content
PPP PPP-5. Potency of cannabis products at retail level, 2009 Part (ii) Sources of information
PPP PPP-5. Potency of cannabis products at retail level, 2009 Part (iii) Geographical coverage / Sampling frame / Type of study
PPP PPP-6. Purity of heroin at retail level, 2009 Part (i) Minimum, maximum, mean, median and modal purity recorded (percentage)
PPP PPP-6. Purity of heroin at retail level, 2009 Part (ii) Sources of information
PPP PPP-6. Purity of heroin at retail level, 2009 Part (iii) Geographical coverage / Sampling frame / Type of study / Purity determined to base~salt
PPP PPP-7. Purity of cocaine products at retail level, 2009 Part (i) Minimum, maximum, mean, median and modal purity recorded (percentage)
PPP PPP-7. Purity of cocaine products at retail level, 2009 Part (ii) Sources of information
PPP PPP-7. Purity of cocaine products at retail level, 2009 Part (iii) Geographical coverage / Sampling frame / Type of study / Purity determined to base~salt
PPP PPP-8. Purity of synthetic drugs at retail level, 2009 Part (i) Minimum, maximum, mean, median and modal purity recorded
PPP PPP-8. Purity of synthetic drugs at retail level, 2009 Part (ii) Sources of information
PPP PPP-8. Purity of synthetic drugs at retail level, 2009 Part (iii) Geographical coverage / Sampling frame / Type of study
PPP PPP-9. Composition of illicit drug tablets, 2009 Part (i) Content of synthetic scheduled illicit drugs
PPP PPP-9. Composition of illicit drug tablets, 2009 Part (ii) Sources of information
PPP PPP-9. Composition of illicit drug tablets, 2009 Part (iii) Sampling frame / Type of monitoring system
PPP PPP-9. Composition of illicit drug tablets, 2009 Part (iv) Information available on substances listed in categories 'Miscellaneous' and 'Other'
PPP PPP-9. Composition of illicit drug tablets Part (v) Information available on adulterants, cutting agents and/or impurities
PPP PPP-10. Recent estimates of drug related public expenditure

Page last updated: Friday, 29 April 2011